A US- based ophthalmologist shares perspectives on dry eye epidemiology and describes the patient journeys for the classical conventional dry eye, neurotrophic dry eye, and the neuropathic dry eye. The specialist also provides in-depth insights into treatment landscape, including for the newer-to-market drugs, the outlook for key emerging therapies, and practical access and reimbursement themes.

This interview was conducted on February 06, 2026.

If you are a Datamonitor Healthcare client, you may access the interview from our KOL Insight channel.

If you are a KOL Insight subscriber, you may also access the interview from our KOL Insight portal.

Biomedtracker’s KOL Insight transcripts are available through subscription only. For more information on obtaining a KOL Insight subscription, please email Biomedtracker or call Biomedtracker Client Services at (888) 670-8900. 

For our disclosures, please read the Biomedtracker Research Standards.